Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Neuroimmunology

Are naturally occurring anti-NMDAR autoantibodies pathogenic?

Autoantibodies against the N-methyl-d-aspartate receptor (NMDAR) are known to cause encephalitis; however, a new study has identified anti-NMDAR antibodies in the absence of encephalitis in various mammalian species. These chronically produced natural antibodies might function in physiological target protein modulation and contribute to the symptoms of non-immune diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R. & Balice-Gordon, R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 10, 63–74 (2011).

    Article  CAS  Google Scholar 

  2. Pan, H. et al. Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model. Mol. Psychiatry https://doi.org/10.1038/s41380-017-0011-3 (2018).

  3. Dahm, L. et al. Seroprevalence of autoantibodies against brain antigens in health and disease. Ann. Neurol. 76, 82–94 (2014).

    Article  CAS  Google Scholar 

  4. Gresa-Arribas, N. et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 13, 167–177 (2014).

    Article  CAS  Google Scholar 

  5. Saito, M. et al. 121. Differences between auto-antibody titres in cerebrospinal fluids and sera of patients with anti-N-methyl-D receptor encephalitis. Schizophr. Bull. 43 (Suppl. 1), S67–S68 (2017).

    Article  Google Scholar 

  6. Planaguma, J. et al. Human N-methyl d-aspartate receptor antibodies alter memory and behaviour in mice. Brain 138, 94–109 (2015).

    Article  Google Scholar 

  7. Li, Y., Tanaka, K., Wang, L., Ishigaki, Y. & Kato, N. Induction of memory deficit in mice with chronic exposure to cerebrospinal fluid from patients with anti-N-methyl-d-aspartate receptor encephalitis. Tohoku J. Exp. Med. 237, 329–338 (2015).

    Article  CAS  Google Scholar 

  8. Nagele, E. P. et al. Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease. PLOS ONE 8, e60726 (2013).

    Article  CAS  Google Scholar 

  9. Burnashev, N. & Szepetowski, P. NMDA receptor subunit mutations in neurodevelopmental disorders. Curr. Opin. Pharmacol. 20, 73–82 (2015).

    Article  CAS  Google Scholar 

  10. van Zundert, B., Yoshii, A. & Constantine-Paton, M . Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal. Trends Neurosci. 27, 428–437 (2004).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The author's work is supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI grant no. JP 17K11477.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keiko Tanaka.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanaka, K. Are naturally occurring anti-NMDAR autoantibodies pathogenic?. Nat Rev Neurol 14, 255–256 (2018). https://doi.org/10.1038/nrneurol.2018.41

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2018.41

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing